Zhengzhou RAAS

Zhengzhou RAAS is a Chinese biotechnology company specializing in the research, development, and manufacturing of plasma-derived medicinal products. As a key subsidiary of Shanghai RAAS Blood Products, the company operates advanced plasma fractionation facilities to produce essential therapies including human albumin, intravenous immunoglobulin (IVIG), and coagulation factors. Its products are primarily used to treat life-threatening conditions such as hemophilia, immune system deficiencies, and severe blood loss. Zhengzhou RAAS plays a critical role in the regional supply chain for blood products within Henan province and across China.